ARTICLE | Clinical News
Peregrine preclinical data
October 20, 2014 7:00 AM UTC
In vitro data showed that bavituximab specifically binds to cells infected with Ebola virus and to purified Ebola virions. Data will be published in the Journal of Immunology Research. Bavituximab is ...